A PYMNTS Company

US/EU: EC to decide next month on $13.4B pharma merger

By  |  June 5, 2014

The European Commission is slated to rule by July 9 on the latest in a series of consolidation deals in the globe’s pharmaceutical industry.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    According to reports, the Commission is set to decide on whether to approve of Zimmer Holding’s offer for Biomet; the US-based orthopedic product maker submitted a bid of $13.4 billion.

    According to reports, it would make Zimmer the world’s second-largest company in the industry behind Johnson & Johnson.

    According to the Commission Zimmer first filed for EU clearance of the deal on June 3. The companies said they expect to finalize the deal in the first quarter of 2015.

    Full content: Euronews

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.